Results 21 to 30 of about 49,377 (194)
Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
International Journal of General Medicine, 2023 Ali Al-Jumaili,1 Haider N Dawood,2 Delan Ikram,3 Ali Al-Jabban3 1Pediatric Department, Central Pediatric Teaching Hospital, Baghdad, Iraq; 2Internal Medicine Department, Al-Imamain Al-Kadhimin Medical City, Baghdad, Iraq; 3Medical Department, Pfizer ...
Al-Jumaili A +3 more
doaj
Promising Expectations for Pneumococcal Vaccination during COVID-19
Vaccines, 2021 The emergence of new viral infections has increased over the decades. The novel virus is one such pathogen liable for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, popularly known as coronavirus disease 2019 (COVID-19).
Hyobin Im +3 more
doaj +1 more source
Pneumococcal Disease in High-Risk Adults in Lebanon: Expert Opinion
Vaccines, 2022 Pneumococcal disease affects people across all ages but is more prevalent in young children and the elderly. Despite the availability of the pneumococcal vaccine for adults, the disease burden and mortality associated with it remains a challenge.
Abdulrahman Bizri +9 more
doaj +1 more source
Regulation of naturally acquired mucosal immunity to Streptococcus pneumoniae in healthy Malawian adults and children. [PDF]
PLoS ONE, 2012 Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. In adults, disease rates decline following intermittent colonization and the acquisition of naturally acquired immunity.
Sarah J Glennie +5 more
doaj +1 more source
mSphere, 2022 Streptococcus pneumoniae is a major cause of community-acquired pneumonia (CAP) in young children, older adults, and those with immunocompromised status.
Gowrisankar Rajam +14 more
doaj +1 more source
Emerging Microbes and Infections, 2021 Few studies on adult pneumococcal septic arthritis are sufficiently large enough to assess both epidemiological trends following routine pneumococcal immunization and clinical disease. With major shifts in serotypes causing invasive pneumococcal disease (
Catherine Hyams +7 more
doaj +1 more source
Burden of Invasive Pneumococcal Disease
Clinical Infectious Diseases, 2019 TO THE EDITOR—We read with interest the article by Kent et al [1]. The authors note that the burden of invasive pneumococcal disease (IPD) in UK infants aged
Slack, Mary +6 more
openaire +4 more sources
Hospitalization rates for pneumococcal disease in Brazil, 2004 - 2006
Revista de Saúde Pública, 2011 OBJECTIVE: To estimate hospitalization rates for pneumococcal disease based on the Brazilian Hospital Information System (SIH). METHODS: Descriptive study based on the Hospital Information System of Brazilian National Health System data from January 2004
Hillegonda Maria Dutilh Novaes +2 more
doaj +1 more source
Pneumococcal disease surveillance in Europe
Eurosurveillance, 2006 Pneumococcal disease (Pnc) is responsible for invasive pneumococcal disease (IPD) – mainly meningitis and septicaemia - and is an infection of public health importance in Europe. Following the licensure of an effective conjugate vaccine (PCV) in Europe, several European countries, including France, Germany, the Netherlands, Norway, Spain and the United
R G, Pebody +4 more
openaire +4 more sources
The remaining challenges of pneumococcal disease in adults [PDF]
European Respiratory Review, 2012 Pneumococcal disease can be divided into invasive disease, i.e. when bacteria are detected in normally sterile body fluids, and noninvasive disease. Pneumococcal disease occurs more frequently in younger children and older adults.
E. Ludwig +4 more
doaj